Our analysis using the TCGA database revealed that EZH2 and MYC were upregulated across multiple human tumors, including stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), and rectum adenocarcinoma (READ) (Figure S7A, Supporting Information). Here, EZH2 is linked to gastric adenocarcinoma.